SEC 13F Intelligence

Ergoteles LLC / AMED

Ergoteles LLC’s Amedisys Inc Position

Does Ergoteles LLC own Amedisys Inc (AMED)? Yes — 33.9K shares worth $3M (+4.64% of its 13F portfolio) as of Q3 2023, down from 38.6K shares the prior filed quarter.

Position Value
$3M
Q3 2023
Shares
33.9K
% of Portfolio
+4.64%
Quarters Held
9
currently held

Position History AMED

Reported value by quarter
Q4 ’20: $835,000Q4 ’20Q1 ’21: $2MQ2 ’21: $563,000Q2 ’21Q1 ’22: $651,000Q2 ’22: $1MQ2 ’22Q4 ’22: $1MQ1 ’23: $1MQ1 ’23Q2 ’23: $4MQ3 ’23: $3MQ3 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q3 202333.9K$3M+4.64%
Q2 202338.6K$4M+0.17%
Q1 202314.0K$1M+0.04%
Q4 202217.2K$1M+0.05%
Q2 202212.7K$1M+0.04%
Q1 20223.8K$651,000+0.02%
Q2 20212.3K$563,000+0.01%
Q1 20218.0K$2M+0.07%
Q4 20202.8K$835,000+0.03%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Ergoteles LLC’s full portfolio or all institutional holders of AMED.